New $22 Million Project Targets Deadly Viruses

April 3, 2019—(BRONX, N.Y.)—The National Institute of Allergy and Infectious Diseases (NIAID) has awarded an international consortium led byAlbert Einstein College of Medicine a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Source: Einstein News - Category: Universities & Medical Training Source Type: news